Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» FDA
FDA
FDA should listen to patients, not just clinical trial data, on rare disease therapies
Stat
Tue, 05/10/16 - 09:42 am
Marco Rubio
FDA
orphan diseasese
Rare Diseases
patients
Theravance Gets FDA Nod on Vibativ
24/7 Wall St
Mon, 05/9/16 - 10:42 am
Theravance
FDA
Vibativ
SAB
antibiotics
The FDA Should Remove Warning Label On The Smoking Cessation Drug Chantix
Forbes
Thu, 05/5/16 - 10:04 am
FDA
warnings
Pfizer
Chantix
smoking cessation
Panel: Painkiller training should be required for physicians
Yahoo/AP
Wed, 05/4/16 - 06:47 pm
painkillers
physicians
FDA
opioids
Generic drug backlog persists as FDA slowly clears applications
BioPharma Dive
Wed, 05/4/16 - 06:42 pm
FDA
generics
Commonly used drug can cause uncontrollable urge to gamble and have sex, FDA says
Stat
Tue, 05/3/16 - 09:53 pm
Abilify
antipsychotic
FDA
Otsuka
Bristol-Myers Squibb
U.S. approves first drug for psychosis linked to Parkinson's
Yahoo/Reuters
Sat, 04/30/16 - 10:42 am
Parkinson's Disease Psychosis
FDA
Acadia
Nuplazid
FDA sued for hiding too much info about its expert panel members
Stat
Thu, 04/28/16 - 05:55 pm
FDA
advisory panels
Sarepta Therapeutics shares surge 20% after article suggests drug approval possible
Marketwatch
Thu, 04/28/16 - 09:36 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
FDA
advisory panels
eteplirsen
FDA wants more from Proteus, Otsuka on ‘smart pill’
Mass Device
Wed, 04/27/16 - 10:04 pm
FDA
Proteus
Otsuka
Abilify
antidepressants
smart pills
Does FDA’s Per Se Prohibition Against Off-Label Promotion Have a Future?
FDA Law Blog
Wed, 04/27/16 - 02:10 pm
FDA
off-label
free speech
Here Are Three Ways To Prevent Tragic Battles Between The FDA And Patients
Forbes
Wed, 04/27/16 - 09:06 am
FDA
patients
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
Biotech stock crashes 50% after disclosing bad news from the FDA
Yahoo/Business Insider
Tue, 04/26/16 - 09:45 am
Sarepta Therapeutics
eteplirsen
FDA
Duchenne Muscular Dystrophy
FDA panel votes against Sarepta’s drug for Duchenne muscular dystrophy
Stat
Mon, 04/25/16 - 09:57 pm
FDA
Sarepta Therapeutics
eteplirsen
advisory panels
Duchenne Muscular Dystrophy
AbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEKIRA PAKwithout Ribavirin in Genotype 1b Chronic Hepatitis C Patients with Compensated Cirrhosis
Yahoo
Mon, 04/25/16 - 06:39 pm
AbbVie
FDA
Viekira Pak
hepatitis C
Sarepta Therapeutics FDA Panel Live Blog
TheStreet.com
Mon, 04/25/16 - 08:21 am
Sarepta Therapeutics
eteplirsen
FDA
advisory panels
Duchenne Muscular Dystrophy
An Investors' Guide to Sarepta's Eteplirsen FDA Advisory Panel Meeting
TheStreet.com
Mon, 04/25/16 - 07:56 am
Sarepta Therapeutics
eteplirsen
FDA
advisory panels
Duchenne Muscular Dystrophy
Could Desperate Parents' Pleas Sway The FDA To Approve A Drug Even If Evidence It Works Is Lacking?
Forbes
Sun, 04/24/16 - 04:32 pm
FDA
parents
Duchenne Muscular Dystrophy
Sarepta Therapeutics
eteplirsen
Sarepta shares soar on FDA voting questions
CNBC
Fri, 04/22/16 - 09:38 pm
Sarepta
FDA
eteplirsen
Duchenne Muscular Dystrophy
US FDA centralizes effort to address combination product issues
Mass Device
Fri, 04/22/16 - 11:14 am
FDA
Pages
« first
‹ previous
…
275
276
277
278
279
280
281
282
283
…
next ›
last »